S Cocca1, M Guarino2, M Cicala2. Show Affiliations » 1. Department of Gastrointestinal Diseases, Campus Bio-Medico University, Rome, Italy s.cocca@unicampus.it. 2. Department of Gastrointestinal Diseases, Campus Bio-Medico University, Rome, Italy.
Abstract
Entities: Disease Gene Species
Mesh: See more » AdultAnimalsAsymptomatic InfectionsCrohn Disease/drug therapyGastrointestinal Agents/adverse effectsGastrointestinal Agents/therapeutic useHumansInfliximab/adverse effectsInfliximab/therapeutic useMaleTaenia saginataTaeniasis/diagnosisTaeniasis/etiologyTumor Necrosis Factor-alpha/antagonists & inhibitors
Substances: See more » Gastrointestinal AgentsTumor Necrosis Factor-alphaInfliximab
Year: 2016 PMID: 27208388 DOI: 10.1093/ecco-jcc/jjw109
Source DB: PubMed Journal: J Crohns Colitis ISSN: 1873-9946 Impact factor: 9.071